Ignite Creation Date:
2024-05-06 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05949541
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2023-07-09
Brief Title:
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HRHER2- SNF1-subtype Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
SCHBCC-N062
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhimin Shao
Responsible Party Title:
Director of General Surgery of Fudan Shanghai Cancer Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None